✦ LIBER ✦

Randomized Phase III Trial Results of Panitumumab, a Fully Human Anti—Epidermal Growth Factor Receptor Monoclonal Antibody, in Metastatic Colorectal Cancer

✍ Scribed by Tara Beers Gibson; Aarati Ranganathan; Axel Grothey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recent Results and Ongoing Trials with P

✍ Preeta Tyagi; Edward Chu; Vinay K. Jain 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 88 KB

Panitumumab: Human monoclonal antibody a

✍ Mei Wu; Anastasia Rivkin; Trinh Pham 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Clinical Use of Anti-Epidermal Growth Fa

✍ Dina K. Patel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

First-Line Use of Anti–Epidermal Growth

✍ James J. Lee; Edward Chu 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 103 KB

ABX-EGF, a fully human anti-epidermal gr

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

The role of anti-epidermal growth factor

✍ Olivier Bouché; Giordano Domenico Beretta; Pilar García Alfonso; Michael Geissle 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 370 KB